UWMDI Co-Director Michael Schwartz, MD, awarded Novo Nordisk Research Agreement

UWMDI Co-Director Michael Schwartz, MD, awarded Novo Nordisk Research Agreement

Dr. Michael Schwartz has received a $1M research grant with Novo Nordisk. This two-year project seeks to identify neurons in the brain that detect and respond to changes of the circulating glucose level and determine their roles in glucose homeostasis. Co-investigators on the project are UWMDI researchers Gregory Morton, PhD and Jarrad Scarlett, MD, PhD.  Dr. Schwartz is the RH Williams Endowed Chair in Medicine and a Professor in the Division of Metabolism, Endocrinology and Nutrition.